Stock A018680 SEOUL PHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Seoul Pharma Co., Ltd

Equities

A018680

KR7018680009

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
3,405 KRW +1.04% Intraday chart for Seoul Pharma Co., Ltd +2.56% -11.10%
2020 Seoul Pharma Co., Ltd announced that it has received KRW 15 billion in funding from 2018 QCP 13th Private Equity Fund Co., Ltd. CI
2020 2018 QCP 13th Private Equity Fund Co., Ltd. completed the acquisition of 44.68% stake in Seoul Pharma Co., Ltd from a group of shareholders. CI

Business Summary

Seoul Pharma Co Ltd is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Company’s main products portfolio consists of drugs for cardio-vascular system, respiratory system and digestive system, antidiabetic drugs, anti-obesity drugs, antipyretic drugs, analgesic drugs, anti-inflammatory drugs, antibiotics, antibacterials, antifungal drugs, antiviral drugs, tonics, vitamins, minerals, creams, dugs for hypertension, antipyretics, drugs for skin disease, dugs for cough and phlegm redution, as well as ointments, among others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 172

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
50,057 100.0 % 52,459 100.0 % +4.80%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.7 %
49,351 98.6 % 51,267 97.7 % +3.88%
Overseas
2.3 %
706 1.4 % 1,191 2.3 % +68.82%

Managers

Managers TitleAgeSince
Dong-Hyun Yoon CEO
 Chief Executive Officer 49 -
Bong-Hwan Shin CEO
 Chief Executive Officer 66 -
Se-Young Lee DFI
 Director of Finance/CFO 54 -
Hoon-Mo Koo AUD
 Comptroller/Controller/Auditor 58 22-03-24
Jung-Yul Lee SAM
 Sales & Marketing 50 16-08-21

Members of the board

Members of the board TitleAgeSince
Hee-Yeon Hwang BRD
 Director/Board Member 52 -
Dong-Hyun Yoon CEO
 Chief Executive Officer 49 -
Myung-Ki Son BRD
 Director/Board Member 44 -
Kyu-Sik Park BRD
 Director/Board Member 60 20-03-26
Han-Soo Kim BRD
 Director/Board Member 60 20-03-26
Bong-Hwan Shin CEO
 Chief Executive Officer 66 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,659,319 4,732,808 ( 40.59 %) 0 40.59 %

Holdings

NameEquities%Valuation
SG GLOBAL CO.,LTD.
90.91%
 100 90.91% 149 $

Company contact information

SEOUL PHARMA Co., Ltd.

124-31 Osongsaengmyeong 6-ro Osong-eup

28158, Cheongju

+

http://www.seoulpharma.com
address Seoul Pharma Co., Ltd(A018680)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
SEOUL PHARMA CO., LTD Stock Seoul Pharma Co., Ltd
-11.10% 29.3M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.41% 43.48B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.65B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.67% 14.73B
CIPLA LIMITED Stock Cipla Limited
+14.21% 13.79B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+48.11% 12.04B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.08B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.90% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A018680 Stock
  4. Company Seoul Pharma Co., Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW